TERN stock

Terns Pharmaceuticals Inc (TERN) financials · $6.12B cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Terns Pharmaceuticals Inc (TERN) $6.12B cap.

Cached annual income statement
LineFY2024FY2023
Net Income-$88.9M-$90.2M
EPS (Diluted)-$1.12-$1.27
Cached annual balance sheet
LineFY2024FY2023
Total Assets$363.9M$268.5M
Cash & Equivalents$161.4M$79.9M
Total Liabilities$18.1M$13.2M
Cached annual cash flow
LineFY2024FY2023
Operating Cash Flow-$70.0M-$67.4M
Investing Cash Flow-$12.4M-$38.0M
Financing Cash Flow$164.0M$42.0M
These statements as JSON? API free 100/day

FAQ

What is TERN P/E and revenue?

Terns Pharmaceuticals Inc (TERN) $6.12B cap.

What is TERN revenue?

TERN income-statement cache has no revenue figure yet.

Is TERN profitable?

Terns Pharmaceuticals Inc last cached net income is -$88.9M (FY2024).

What are TERN total assets?

Terns Pharmaceuticals Inc last cached total assets are $363.9M (FY2024).

What is TERN free cash flow?

No cached cash-flow row for TERN yet.

Not investment advice. Cached statements, not a live tape.